Fragile X Pre-mutation and Ovarian Function

Submission Date: June 5, 2007

Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.

This funding opportunity announcement, issued by the National Institute of Child Health and Human Development, National Institutes of Health, solicits Research Project Grant (R01) applications from institutions/organizations that propose basic, clinical or translational research on the effects of the Fragile X pre-mutation on ovarian function, with a focus on premature ovarian failure or early menopause, in women and/or animal models.

For more information, visit the Fragile X Pre-mutation and Ovarian Function webpage.